Douglas L Seidner Selected Research

teduglutide

1/2021	Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
1/2020	Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
1/2020	Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.
1/2020	Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials.
1/2020	Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
8/2018	Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
1/2018	Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
6/2015	Effect of Teduglutide, a Glucagon-like Peptide 2 Analog, on Citrulline Levels in Patients With Short Bowel Syndrome in Two Phase III Randomized Trials.
3/2013	Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure.
12/2012	Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas L Seidner Research Topics

Disease

12	Short Bowel Syndrome 01/2021 - 06/2003
12	Intestinal Failure 01/2021 - 06/2003
5	Diarrhea 01/2018 - 06/2003
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 12/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 08/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2013
2	Inflammation (Inflammations) 01/2021 - 04/2005
2	Vascular Diseases (Vascular Disease) 01/2020 - 01/2018
2	Crohn Disease (Crohn's Disease) 08/2011 - 06/2008
2	Malnutrition (Nutritional Deficiencies) 03/2007 - 10/2005
2	Osteomalacia 08/2004 - 09/2002
2	Osteoporosis 08/2004 - 09/2002
2	Metabolic Bone Diseases (Osteopenia) 08/2004 - 09/2002
1	Magnesium Deficiency (Deficiency, Magnesium) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Polyps 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 11/2019
1	Adenoma (Adenomas) 10/2019
1	Ovarian Neoplasms (Ovarian Cancer) 10/2019
1	Carcinogenesis 10/2019
1	Atrophy 03/2018
1	Celiac Disease (Celiac Sprue) 03/2018
1	Sarcopenia 01/2017
1	Overweight 01/2017
1	Vitamin D Deficiency 08/2013
1	Hypophosphatemic Rickets 08/2013
1	Weight Loss (Weight Reduction) 03/2013
1	Bone Diseases (Bone Disease) 03/2007
1	Liver Diseases (Liver Disease) 05/2006
1	Liver Failure 05/2006
1	Dehydration (Water Stress) 10/2005
1	Ulcerative Colitis 04/2005
1	Hemorrhage 02/2005
1	Stomach Ulcer (Gastric Ulcer) 02/2005
1	Weight Gain 08/2004
1	Persistent Left Superior Vena Cava 05/2004
1	Enteritis 12/2003
1	Sepsis (Septicemia) 03/2003
1	Infections 03/2003
1	Catheter-Related Infections 03/2003
1	Adjustment Disorders (Adjustment Disorder) 03/2003
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 11/2002
1	Body Weight (Weight, Body) 11/2002

Drug/Important Bio-Agent (IBA)

10	teduglutideIBA 01/2021 - 12/2012
3	MagnesiumIBA 01/2021 - 08/2013
3	Fish OilsIBA 08/2011 - 04/2005
3	ElectrolytesIBA 10/2005 - 06/2003
2	Vitamin D FDA LinkGeneric 01/2021 - 08/2013
2	CitrullineIBA 01/2020 - 06/2015
2	CalciumIBA 01/2020 - 10/2019
2	AntioxidantsIBA 08/2011 - 04/2005
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 08/2011 - 04/2005
2	Volatile Fatty AcidsIBA 07/2007 - 04/2005
2	LipidsIBA 07/2007 - 05/2006
2	AlbuminsIBA 05/2006 - 11/2002
1	Glutens (Glutelin)IBA 03/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Glucagon-Like Peptide 2IBA 06/2015
1	hydroxide ionIBA 08/2013
1	PrebioticsIBA 08/2011
1	FatsIBA 07/2007
1	GlucocorticoidsIBA 03/2007
1	EmulsionsIBA 05/2006
1	EnzymesIBA 05/2006
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	BilirubinIBA 05/2006
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2006
1	Alkaline PhosphataseIBA 05/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2005
1	Growth Hormone (Somatotropin)IBA 08/2004
1	Glutamine (L-Glutamine)FDA Link 08/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2003
1	AntidiarrhealsIBA 12/2003
1	ORALIT (ORS)IBA 06/2003
1	ZincIBA 06/2003
1	4-toluenesulfonyl fluoride (TSF)IBA 11/2002
1	Transferrin (beta 2 Transferrin)IBA 11/2002
1	Proteins (Proteins, Gene)FDA Link 11/2002

Therapy/Procedure

10	Parenteral Nutrition 01/2020 - 09/2002
3	Therapeutics 03/2018 - 12/2003
2	Catheters 05/2004 - 03/2003
1	Aftercare (After-Treatment) 01/2020
1	Ileostomy 01/2018
1	Jejunostomy 01/2018
1	Nutrition Therapy (Medical Nutrition Therapy) 01/2017
1	Enteral Nutrition (Feeding, Tube) 06/2008
1	Punctures 02/2005
1	Gastrostomy 02/2005
1	Central Venous Catheters 05/2004
1	Oral Administration 12/2003
1	Fluid Therapy (Oral Rehydration Therapy) 06/2003
1	Home Parenteral Nutrition 03/2003
1	Patient Readmission 03/2003